TAPBP and neuroblastoma: Next, to determine whether tapasin-TM–mediated stabilization would be applicable to other cell lines with varying degrees of HLA-I production, we used cycloheximide and brefeldin A treatment followed upon with W6/32 antibody labeling across five neuroblastoma lines.